Secukinumab responses vary across the spectrum of congenital ichthyosis in adults
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Secukinumab responses vary across the spectrum of congenital ichthyosis in adults
Authors
Keywords
-
Journal
ARCHIVES OF DERMATOLOGICAL RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-26
DOI
10.1007/s00403-022-02325-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pathogenesis-Based Therapy With Repurposed Biologics for Monogenic Inflammatory Skin Disorders
- (2020) Amy S. Paller JAMA Dermatology
- Secukinumab Therapy for Netherton Syndrome
- (2020) Isabelle Luchsinger et al. JAMA Dermatology
- Transepidermal water loss in the orphan forms of ichthyosis
- (2020) Taylor R. Erickson et al. PEDIATRIC DERMATOLOGY
- Secukinumab for the treatment of SAM syndrome associated with desmoglein‐1 deficiency
- (2020) L.H. Frommherz et al. BRITISH JOURNAL OF DERMATOLOGY
- Hair and skin predict cardiomyopathies: Carvajal and erythrokeratodermia cardiomyopathy syndromes
- (2020) Qisi Sun et al. PEDIATRIC DERMATOLOGY
- IL-17A inhibition by secukinumab induces early clinical, histopathological, and molecular resolution of psoriasis
- (2019) James G. Krueger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Imbalance in T-Helper 17 Cells and Targeted Therapy in an Infant with SAM-like Syndrome
- (2019) Angela Hernández-Martín et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ichthyosis molecular fingerprinting shows profound T H 17 skewing and a unique barrier genomic signature
- (2018) Kunal Malik et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The Major Orphan Forms of Ichthyosis Are Characterized by Systemic T-Cell Activation and Th-17/Tc-17/Th-22/Tc-22 Polarization in Blood
- (2018) Tali Czarnowicki et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The spectrum of manifestations in desmoplakin gene ( DSP ) spectrin repeat 6 domain mutations: Immunophenotyping and response to ustekinumab
- (2018) Amy S. Paller et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- An IL-17–dominant immune profile is shared across the major orphan forms of ichthyosis
- (2017) Amy S. Paller et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Establishing and Validating an Ichthyosis Severity Index
- (2017) Nareh V. Marukian et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial
- (2015) Diamant Thaçi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- IQoL-32: A new ichthyosis-specific measure of quality of life
- (2013) Isabelle Dreyfus et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now